M6 – Mendoza
Currently, several brands of blood pressure medication known as “Angiotensin II Receptor Blocker (ARB)” are being recalled by the FDA and their manufacturer due to the presence of known carcinogens in the medication. Due to the recall, there are current investigations ongoing to determine which ARB medications are free of the contaminant and which must be removed before reaching consumers. There are as of yet no legal repercussions or policy changes, but that is yet to be seen depending on the scope of contamination and if any harm has been caused by the defect directly.
American Heart Assocation. (2019). “Q&A High Blood Pressure Medication Recall”. American Heart Assocation, Retrieved from https://www.heart.org/en/health-topics/high-blood-pressure/changes-you-can-make-to-manage-high-blood-pressure/qa-high-blood-pressure-medication-recall. Accessed 30 June 2019.
Carroll, Linda. (27 June 2019). “FDA once again expands recall of blood pressure drugs”. NBCnews.com, Retrieved from https://www.nbcnews.com/health/health-news/fda-once-again-expands-recall-blood-pressure-drugs-n1023446. Accessed 29 June 2019.